First approved treatment in Japan for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) Approval is based on positive Phase III data from multinational and Japanese studies in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results